Using the data for Brady and Co. provided in the sheet labeled "Trial Balance" prepare Statement of Retained Earnings for 2016.

		2015			2016
		Dr	Cr		Dr	Cr
Accounts Payable			999,210			1,079,837
Accounts Receivable		2,943,125			3,245,967
Accrued Liabilities - Other			508,643			721,358
Accrued Pension Liabilities			650,216			450,356
Accrued Restructuring Charges			126,000			90,476
Accrued Salaries, Wages and Commissions			281,364			350,191
Accumulated Other Comprehensive Income (Loss)		621,236				85,000
Accumulated Depreciation - Property, Plant & Equipment			1,829,634			1,999,999
Accumulated Post-Employment Benefit Obligation (long-term)			802,316			402,634
Additional Paid-in Capital, Common Stock			299,304			299,304
Additional Paid-in Capital, Preferred Stock			75			75
Allowance for Doubtful Accounts			125,436			124,645
Bonds Payable			244,563			249,046
Cash and Cash Equivalents		401,236			751,329
Common Stock ($1.00 par value) authorized 900 million shares issued 300 million shares in 2016, 284 million in 2015			300,000			284,000
Cost of Goods Sold		3,000,235			2,763,584
Current Portion of Long-term Debt			720,125			849,869
Deferred Tax Assets (current)		62,596			81,236
Deferred Tax Liabilities (long-term)			229,000			440,263
Depreciation Expense		307,200			311,236
Dividends - Common		292,351			214,956
Dividends - Preferred		2,000			945
General & Administrative Expenses		1,732,429			1,459,695
Goodwill and Other Intangibles		3,212,491			3,212,491
Income Taxes Payable			246,002			102,563
Interest Expense		201,366			250,000
Interest Income			10,126			18,227
Investments in unconsolidated affiliated companies		1,235,000			1,456,896
Inventories		163,214			224,561
Long-term Debt			3,223,713			3,702,700
(Loss) Income from Discontinued Operations, net of tax		28,100				7,453
Preferred Stock ($10 par value) authorized 10 million shares issued 90,000 shares in 2016, 90,000 in 2015			900			900
Prepaid Expenses		141,029			170,296
Property, Plant and Equipment		2,943,216			3,936,726
Provision for income taxes		245,105			201,636
Research and Development Expenses		199,500			496,597
Restructuring Charges		199,506			255,013
Retained Earnings, beginning			2,960,256			5,173,286
Sales			8,430,061			6,526,967
Selling Expenses		19,365			58,890
Short-term Investments		20,000			26,800
Treasury Stock, at cost - 117,156,719 shares in 2016 and 108,822,953 shares in 2015		4,472,969			4,263,984
Unearned Revenues			456,325			423,689
		22,443,269	22,443,269		23,382,838	23,382,838